Atlas Trials

N Meningitidis Serogroup B

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch N Meningitidis Serogroup B

RecordFirmDate
A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years. (NCT01323270)Pfizer2011-03-18

Track N Meningitidis Serogroup B automatically

Every clearance here is in the API, with alerts when new ones post.